Subject# | Treatment type | ALT (U/L) baseline | ALT (U/L) peak | Peak ALT(ULN) | AST (ULN) | ALP (ULN) | Total bilirubin (ULN) |
---|---|---|---|---|---|---|---|
1 | Placebo | 16 | 273 | 6.1 | 1.8 | 1.0 | 0.6 |
2 | Placebo | 19 | 320 | 9.4 | 3.6 | 0.7 | 0.4 |
3 | Placebo | 15 | 967 | 28.4 | 10.9 | 0.9 | 0.6 |
4 | Placebo | 18 | 119 | 3.5 | 1.9 | 0.7 | 0.5 |
5 | Placebo | 16 | 145 | 4.3 | 2.6 | 0.6 | 0.8 |
6 | Placebo | 12 | 146 | 4.3 | 2.6 | 0.6 | 0.4 |
7 | Moxifloxacin | 33 | 164 | 3.6 | 1.8 | 1.1 | 0.3 |
8 | Moxifloxacin | 32 | 173 | 3.8 | 2.0 | 0.6 | 0.5 |
9 | Moxifloxacin | 30 | 229 | 5.1 | 2.7 | 1.4 | 0.9 |
10 | Moxifloxacin | 14 | 142 | 3.2 | 1.5 | 0.7 | 0.9 |
11 | Moxifloxacin | 20 | 136 | 4.0 | 1.9 | 0.8 | 0.4 |